News
Investing.com — BioCryst Pharmaceuticals , Inc. (NASDAQ:BCRX), dessen Aktie in den letzten sechs Monaten um über 45% gestiegen ist und derzeit bei etwa 10,21 US-Dollar notiert, hat neue Daten aus der ...
Stocktwits on MSN1d
Retail Buzz Intensifies Around Quoin Pharma Stock After Positive Pediatric Skin Study DataShares of Quoin Pharmaceuticals saw increased retail chatter on Wednesday after the company announced positive initial ...
Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced that it will present a poster ...
Shares of Quoin Pharmaceuticals surged 47.5% Wednesday morning. The stock is higher following the release of promising ...
QRX003 is being well tolerated by the patient and no adverse events have been reported. As a result of these positive initial ...
Der Patient hat gut auf QRX003 angesprochen, ohne dass unerwünschte Ereignisse gemeldet wurden, und die Behandlung soll mit einer weiteren Bewertung nach 24 Wochen fortgesetzt werden. Die positiven ...
Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...
Announced Positive Clinical Data for Adult and Pediatric Netherton Patients ASHBURN, Va., May 13, 2025 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback